- Home
- PIM vs AMRN Comparison
PIM vs AMRN Comparison
Compare PIM & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PIM
- AMRN
- Stock Information
- Founded
- PIM 1988
- AMRN 1989
- Country
- PIM United States
- AMRN Ireland
- Employees
- PIM N/A
- AMRN N/A
- Industry
- PIM Finance Companies
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- PIM Finance
- AMRN Health Care
- Exchange
- PIM Nasdaq
- AMRN Nasdaq
- Market Cap
- PIM 160.0M
- AMRN 189.2M
- IPO Year
- PIM N/A
- AMRN 1993
- Fundamental
- Price
- PIM $3.33
- AMRN $0.59
- Analyst Decision
- PIM
- AMRN Buy
- Analyst Count
- PIM 0
- AMRN 1
- Target Price
- PIM N/A
- AMRN N/A
- AVG Volume (30 Days)
- PIM 57.5K
- AMRN 991.3K
- Earning Date
- PIM 01-01-0001
- AMRN 03-12-2025
- Dividend Yield
- PIM 8.28%
- AMRN N/A
- EPS Growth
- PIM N/A
- AMRN N/A
- EPS
- PIM 0.05
- AMRN N/A
- Revenue
- PIM N/A
- AMRN $241,021,000.00
- Revenue This Year
- PIM N/A
- AMRN N/A
- Revenue Next Year
- PIM N/A
- AMRN N/A
- P/E Ratio
- PIM $63.80
- AMRN N/A
- Revenue Growth
- PIM N/A
- AMRN N/A
- 52 Week Low
- PIM $2.90
- AMRN $0.43
- 52 Week High
- PIM $3.28
- AMRN $1.36
- Technical
- Relative Strength Index (RSI)
- PIM 56.08
- AMRN 55.53
- Support Level
- PIM $3.30
- AMRN $0.56
- Resistance Level
- PIM $3.35
- AMRN $0.59
- Average True Range (ATR)
- PIM 0.04
- AMRN 0.04
- MACD
- PIM 0.00
- AMRN 0.00
- Stochastic Oscillator
- PIM 70.00
- AMRN 71.91
About PIM Putnam Master Intermediate Income Trust
Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.